Lv11
48 积分 2024-06-17 加入
Recent Developments in Cyclin-Dependent Kinase (CDK) PROTAC in Cancer Therapy
1小时前
待确认
Routes to molecular glue degrader discovery
5天前
已完结
Advancing targeted protein degradation for cancer therapy
5天前
已完结
Hijacking Extracellular Targeted Protein Degrader–Drug Conjugates for Enhanced Drug Delivery
7天前
已完结
Evaluation of Cereblon-Directing Warheads for the Development of Orally Bioavailable PROTACs
7天前
已完结
The Discovery of N-((2H-Tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): A Potent and Selective Glucagon Receptor Antagonist
8天前
已完结
Discovery of 3-benzyl-1,3-benzoxazine-2,4-dione analogues as allosteric mitogen-activated kinase kinase (MEK) inhibitors and anti-enterovirus 71 (EV71) agents
12天前
已完结
Molecular glue CELMoD compounds are regulators of cereblon conformation
15天前
已完结
Expanding the reach of molecular glue degraders
19天前
已完结
A rapid imaging-based screen for induced-proximity degraders identifies a potent degrader of oncoprotein SKP2
19天前
已完结
皖公网安备34019202002308
